Exagen Inc reports results for the quarter ended in March - Earnings Summary

Exagen

15/05/2023 22:54

* Exagen Inc  XGN.OQ  reported a quarterly adjusted loss
of 44
cents​​ per share for the quarter ended in March. The mean
expectation of six analysts for the quarter was for a loss of 56
cents per share.
    * Revenue rose 8% to $11.23 million from a year ago;
analysts
expected $9.40 million. 
    * Exagen Inc's reported EPS for the quarter was a loss of 44
cents​.
    * The mean earnings estimate of analysts had risen by
about 19.5%
in the last three months.​ 
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company. 
    * Exagen Inc shares had risen by 20.6% this quarter and
gained 22.1% so far this year.
    * The company reported a quarterly loss of $7.69 million.
    * Wall Street's median 12-month price target for Exagen Inc
is
$6.50 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 5 "strong buy" or "buy," 1
"hold" and no "sell" or "strong sell." 

This summary was machine generated from LSEG Refinitiv data May
15 at 09:54 p.m. UTC. ​All figures in US dollars unless
otherwise stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Mar. 31 2023      -0.56          -0.44          Beat
 Dec. 31 2022      -0.78          -0.83          Missed
 Sep. 30 2022      -0.73          -0.47          Beat
 Jun. 30 2022      -0.57          -0.78          Missed